Qol Holdings Co., Ltd.
Stock Price Chart
2026/04/03 UpdatedPrice Trend
2026/04/03 UpdatedPrice & Trading Details
2026/04/03 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/04/01Shareholder Composition
Updated 2026/04/01Dividend History 1Years Growth
Updated 2026/03/29| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥40 | +25.0% |
| 2024 | ¥32 | 0.0% |
| 2023 | ¥32 | +10.3% |
| 2022 | ¥29 | +3.6% |
| 2021 | ¥28 | - |
Financial Performance
2026/03/29 UpdatedNo financial data available
Latest IR Information
-
Notice Regarding Executive Personnel Changes
At the 34th Annual General Meeting of Shareholders scheduled for June 2026, director candidates will be resolved. Jun Kawaguchi has been selected as a new director candidate, and Yuji Suzuki is scheduled to resign.
Read more -
Notice of Organizational Change and Personnel Changes
On April 1, 2026, an establishment of a headquarters structure by integrating the Pharmacy Business, BPO Business, and Pharmaceutical Business segments, along with multiple executive personnel changes, will be implemented.
Read more -
Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese Standards] (Consolidated)
For the third quarter of the fiscal year ending March 2026, net sales were JPY 216,025 million (9.0% Year-over-Year increase), operating income was JPY 9,415 million (14.7% Year-over-Year decrease), and net income attributable to owners of parent for the quarter...
Read more -
Q3 Financial Results Presentation for Fiscal Year Ending March 2026
Revenue was 216,025 million yen (9.0% YoY increase), and net income attributable to owners of parent for the quarter was 4,671 million yen (32.6% YoY increase), marking a record high since establishment.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥2,100
Rating Score: 3.00 (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Qol Holdings Revamps Board Lineup With New Director, Maintains Core Leadership - TipRanks ↗
Company Information
About
Qol Holdings Co., Ltd., together with its subsidiaries, engages in the pharmacy, BPO, and pharmaceutical businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also provides contract MR staffing; clinical research and development support services in the areas of food and pharmaceuticals; education and training services; and dispatch clinical research associates to support clinical trials. In addition, the company produce sales promotion materials for pharmaceuticals, as well as pamphlets and websites for medical institutions. Further, it engages in pharmaceutical manufacturing business; medical professional referral and dispatch business for the business areas, including pharmacist, medical clerical work, dispensing work, occupational physician, health nurse, nurse, and registered sales clerk; and business succession, health, and productivity management consulting business. The company was formerly known as Qol Co., Ltd. and changed its name to Qol Holdings Co., Ltd. in October 2018. The company was founded in 1992 and is headquartered in Tokyo, Japan.
